Fidelity National Financial, Inc. EVP and Chief Financial Officer Anthony Park filed a Form 4 on November 9, 2026, disclosing a disposition of common stock on November 6, 2026.
Aspen Neuroscience, Inc. (NASDAQ:ASPE) Executive Chair Hasnain Faheem filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of 321,672 shares of common stock on November 5, 2026, through a fully vested restricted stock unit award.
A Schedule 13G was filed on November 9, 2026, by Frazier Life Sciences X, L.P. and related reporting persons, disclosing beneficial ownership of 1,674,321 shares of common stock in Aspen Neuroscience, Inc. following the company's initial public offering.
Peter T. Sadowski, Executive Vice President and Chief Legal Officer of Fidelity National Financial, Inc., filed a Form 4 on November 9, 2026, reporting a disposition of common stock on November 6, 2026.
A group of ARCH Venture-affiliated entities and individuals filed a Schedule 13D with the SEC on November 9, 2026, disclosing a combined beneficial ownership position in Aspen Neuroscience, Inc. common stock as of a triggering event dated November 2, 2026.
Director Glenn Lurie of Avis Budget Group, Inc. filed a Form 4 on November 9, 2026, disclosing three separate sales of common stock totaling 6,101 shares on November 6, 2026.
Director Lynn Krominga of Avis Budget Group, Inc. filed a Form 4 on November 9, 2026, disclosing the sale of a combined 28,404 shares of common stock on November 6, 2026, at weighted average prices of $120.14 and $121.25 per share.
Director Lynda Scearcy of Sierra Bancorp filed a Form 4 on November 9, 2026, reporting two open-market sales of common stock totaling 18,025 shares executed on November 6 and November 9, 2026.
Aaron P. Graft, President and CEO of Triumph Financial, Inc. (NYSE:TFIN), filed a Form 4 on November 9, 2026, disclosing a series of transactions in the company's common stock between November 5 and November 9, 2026.
Langley Steinert, Executive Chair, Director, and 10% Owner of CarGurus, Inc. (NASDAQ:CARG), filed a Form 4 on November 9, 2026, disclosing four sales of Class A Common Stock executed on November 6, 2026, pursuant to a Rule 10b5-1 trading plan.